Trigyn Technologies (NSE:TRIGYN) Might Be Having Difficulty Using Its Capital Effectively

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. In light of that, when we looked at Trigyn Technologies (NSE:TRIGYN) and its ROCE trend, we weren't exactly thrilled.

Understanding Return On Capital Employed (ROCE)

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. Analysts use this formula to calculate it for Trigyn Technologies:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.031 = ₹222m ÷ (₹8.7b - ₹1.6b) (Based on the trailing twelve months to June 2024).

Therefore, Trigyn Technologies has an ROCE of 3.1%. In absolute terms, that's a low return and it also under-performs the IT industry average of 16%.

Check out our latest analysis for Trigyn Technologies

Historical performance is a great place to start when researching a stock so above you can see the gauge for Trigyn Technologies' ROCE against it's prior returns. If you'd like to look at how Trigyn Technologies has performed in the past in other metrics, you can view this free graph of Trigyn Technologies' past earnings, revenue and cash flow.

So How Is Trigyn Technologies' ROCE Trending?

On the surface, the trend of ROCE at Trigyn Technologies doesn't inspire confidence. Around five years ago the returns on capital were 19%, but since then they've fallen to 3.1%. On the other hand, the company has been employing more capital without a corresponding improvement in sales in the last year, which could suggest these investments are longer term plays. It's worth keeping an eye on the company's earnings from here on to see if these investments do end up contributing to the bottom line.

The Bottom Line On Trigyn Technologies' ROCE

In summary, Trigyn Technologies is reinvesting funds back into the business for growth but unfortunately it looks like sales haven't increased much just yet. Investors must think there's better things to come because the stock has knocked it out of the park, delivering a 207% gain to shareholders who have held over the last five years. However, unless these underlying trends turn more positive, we wouldn't get our hopes up too high.

If you'd like to know more about Trigyn Technologies, we've spotted 3 warning signs, and 1 of them is concerning.

While Trigyn Technologies isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.